Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

DuPont climbed as it said strength in electronics, healthcare and water end-markets outweighed the hit from import duties.

Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence (AI)-powered software platforms.

These 10 stocks could mint the next wave of millionaires › SBA Communications (NASDAQ:SBAC), a leading owner and operator of wireless communications towers, announced results for the second quarter on ...

Archer-Daniels-Midland posted its lowest second-quarter profit in five years on Tuesday as U.S. trade upheaval and uncertainty around biofuel policies slowed sales and crimped trading and crop ...

Organon (OGN) delivered earnings and revenue surprises of +6.38% and +2.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Portfolio status: 100% of loans were performing as of Q2 2025; weighted average risk rating held steady at 2.9, with no ...

The chemical-and-materials maker on Tuesday forecast sales around $12.85 billion and adjusted earnings per share around $4.40. The Wilmington, Del., company previously guided for sales between $12.8 ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

The FTSE 100 (^FTSE) and European stocks gained after the opening bell in London, buoyed for a second day as the recovery ...